Raúl M. Luque

9.2k total citations
265 papers, 6.7k citations indexed

About

Raúl M. Luque is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Raúl M. Luque has authored 265 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Endocrinology, Diabetes and Metabolism, 97 papers in Molecular Biology and 73 papers in Epidemiology. Recurrent topics in Raúl M. Luque's work include Growth Hormone and Insulin-like Growth Factors (78 papers), Pituitary Gland Disorders and Treatments (63 papers) and Neuroendocrine Tumor Research Advances (60 papers). Raúl M. Luque is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (78 papers), Pituitary Gland Disorders and Treatments (63 papers) and Neuroendocrine Tumor Research Advances (60 papers). Raúl M. Luque collaborates with scholars based in Spain, United States and Italy. Raúl M. Luque's co-authors include Rhonda D. Kineman, Justo P. Castaño, Manuel D. Gahete, José Córdoba‐Chacón, Manuel Tena‐Sempere, Francisco Gracia‐Navarro, Marı́a M. Malagón, Mario Durán‐Prado, Antonio J. Martínez‐Fuentes and Alejandro Ibáñez‐Costa and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Brain.

In The Last Decade

Raúl M. Luque

256 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raúl M. Luque Spain 47 2.7k 2.1k 1.8k 1.5k 1.3k 265 6.7k
Justo P. Castaño Spain 46 2.1k 0.8× 2.3k 1.1× 2.0k 1.1× 1.4k 0.9× 1.2k 0.9× 250 6.8k
Manuel D. Gahete Spain 36 1.3k 0.5× 1.4k 0.7× 1.0k 0.6× 761 0.5× 713 0.5× 155 3.8k
Maria A. Soos United Kingdom 36 1.8k 0.7× 3.6k 1.7× 1.3k 0.7× 1.8k 1.2× 2.2k 1.7× 62 7.2k
Adrian C. Herington Australia 46 2.8k 1.1× 2.1k 1.0× 379 0.2× 916 0.6× 975 0.7× 183 6.3k
Fredric E. Wondisford United States 56 4.5k 1.7× 4.1k 2.0× 513 0.3× 637 0.4× 944 0.7× 154 9.1k
Jun Nakae Japan 40 1.7k 0.6× 6.1k 2.9× 1.6k 0.9× 516 0.3× 2.3k 1.8× 89 9.0k
Jan Törnell Sweden 36 2.2k 0.8× 3.6k 1.7× 431 0.2× 499 0.3× 1.3k 1.0× 81 6.9k
Naohisa Tamura Japan 37 1.0k 0.4× 2.4k 1.1× 754 0.4× 904 0.6× 1.2k 0.9× 80 6.3k
Riccarda Granata Italy 34 932 0.4× 1.1k 0.5× 722 0.4× 2.1k 1.4× 1.6k 1.2× 104 4.5k
A Enjalbert France 49 3.8k 1.4× 2.7k 1.3× 1.5k 0.8× 435 0.3× 360 0.3× 208 7.4k

Countries citing papers authored by Raúl M. Luque

Since Specialization
Citations

This map shows the geographic impact of Raúl M. Luque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl M. Luque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl M. Luque more than expected).

Fields of papers citing papers by Raúl M. Luque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl M. Luque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl M. Luque. The network helps show where Raúl M. Luque may publish in the future.

Co-authorship network of co-authors of Raúl M. Luque

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl M. Luque. A scholar is included among the top collaborators of Raúl M. Luque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl M. Luque. Raúl M. Luque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pardo, Virginia, Antonio C. Fuentes-Fayos, Juan Aranda, et al.. (2025). MiR-7 inhibits progression of glioblastoma by impairing autophagy resolution, energy metabolism and ECM remodeling. Journal of Experimental & Clinical Cancer Research. 44(1). 237–237.
2.
Bellido, M., et al.. (2025). Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma. Cellular and Molecular Life Sciences. 82(1). 173–173. 2 indexed citations
3.
Alcalá‐Díaz, Juan F., Francisco M. Gutierrez‐Mariscal, Alejandro López‐Moreno, et al.. (2025). A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study. European Heart Journal. 46(22). 2104–2115. 5 indexed citations
4.
Sarmento‐Cabral, André, Oriol Alberto Rangel-Zúñiga, Julia Carrasco‐Valiente, et al.. (2025). miR-191–5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity. Biomedicine & Pharmacotherapy. 189. 118330–118330.
5.
Carrera‐Bastos, Pedro, Marcel H.A. Muskiet, Fernando Mata Ordóñez, et al.. (2025). Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors. Reviews in Endocrine and Metabolic Disorders.
6.
Venegas‐Moreno, Eva, Elena de Dios, Juan Pedro Martı́nez-Barberá, et al.. (2024). Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167543–167543.
7.
Alors‐Pérez, Emilia, Marina Sánchez‐Frías, Andrea Mafficini, et al.. (2024). The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma. Cancer Gene Therapy. 31(11). 1646–1657. 2 indexed citations
8.
Yubero‐Serrano, Elena M., Laura M. López‐Sánchez, Sara Romero-Martín, et al.. (2024). The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. Cellular and Molecular Life Sciences. 82(1). 18–18. 1 indexed citations
9.
Herrera‐Martínez, Aura D., Antonio C. Fuentes-Fayos, André Sarmento‐Cabral, et al.. (2024). Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?. International Journal of Molecular Sciences. 25(4). 2036–2036. 1 indexed citations
10.
Recinella, Lucia, Raúl M. Luque, Daniele Generali, et al.. (2024). The Protective Effects of an Aged Black Garlic Water Extract on the Prostate. Nutrients. 16(17). 3025–3025. 5 indexed citations
11.
Alcalá‐Díaz, Juan F., Gracia M. Quintana‐Navarro, Javier López-Moreno, et al.. (2024). Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study. The World Journal of Men s Health. 43(1). 249–249. 1 indexed citations
12.
Herrera‐Martínez, Aura D., Antonio Casado‐Díaz, María Ángeles Gálvez-Moreno, et al.. (2023). Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment. Frontiers in Endocrinology. 14. 1243906–1243906. 2 indexed citations
13.
Modena, Daniela, Maria Luisa Moras, Giovanni Sandrone, et al.. (2023). Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers. 15(13). 3453–3453. 4 indexed citations
14.
Alcalá‐Díaz, Juan F., Francisco M. Gutierrez‐Mariscal, Silvia de la Cruz, et al.. (2022). Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial. Clinical Nutrition. 41(2). 552–559. 48 indexed citations
15.
Wiedemann, Tobias, Amelie Lupp, Katja Steiger, et al.. (2021). Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. Cancers. 13(12). 3097–3097. 9 indexed citations
16.
Gutierrez‐Mariscal, Francisco M., Antonio García‐Ríos, Purificación Gómez-Luna, et al.. (2020). Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study). BMC Geriatrics. 20(1). 151–151. 7 indexed citations
17.
Fuentes-Fayos, Antonio C., Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. Brain. 143(11). 3273–3293. 56 indexed citations
18.
Sarmento‐Cabral, André, Fernando L‐López, Manuel D. Gahete, Justo P. Castaño, & Raúl M. Luque. (2017). Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways. Molecular Cancer Research. 15(7). 862–874. 31 indexed citations
19.
Díaz‐Rodriguez, Esther, Alejandro Ibáñez‐Costa, Montserrat García-Lavandeira, et al.. (2014). Somatotropinomas, But Not Nonfunctioning Pituitary Adenomas, Maintain a Functional Apoptotic RET/Pit1/ARF/p53 Pathway That Is Blocked by Excess GDNF. Endocrinology. 155(11). 4329–4340. 11 indexed citations
20.
Luque, Raúl M., José Córdoba‐Chacón, Manuel D. Gahete, et al.. (2011). Kisspeptin Regulates Gonadotroph and Somatotroph Function in Nonhuman Primate Pituitary via Common and Distinct Signaling Mechanisms. Endocrinology. 152(3). 957–966. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026